Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...

More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match ...

The major pharmas are loaded up with trillions in firepower—but are sticking to mid-cap deals. One expert says it might be ...

The U.S. is the biggest single market for most pharma and biotech firms. Among the 10 largest biopharmaceutical companies in the Stoxx 600 health index, five get a majority of their total sales from ...

Retail traders debated the timing and pricing of the buyout, with some expecting an all-cash offer and others speculating ...

Add Yahoo as a preferred source to see more of our stories on Google. Nine big pharma companies have reached agreements with the Trump administration to lower prices for certain drugs in the US under ...

Why price, manufacturing and innovation are so intertwined for pharma. Europe’s pharmaceutical industry needs to m ...

Executive compensation continues to be one of the most polarizing topics in pharma. An industry that generates trillions of dollars in revenue also features millions paid to CEOs and other top ...

TrumpRx aims to lower drug prices in the U.S. by matching the lowest prices charged in other developed countries.